Robert Houle

823 total citations
26 papers, 577 citations indexed

About

Robert Houle is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Robert Houle has authored 26 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Molecular Biology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Robert Houle's work include Drug Transport and Resistance Mechanisms (12 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Receptor Mechanisms and Signaling (6 papers). Robert Houle is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Pharmacological Effects and Toxicity Studies (7 papers) and Receptor Mechanisms and Signaling (6 papers). Robert Houle collaborates with scholars based in Canada, United States and United Kingdom. Robert Houle's co-authors include Chantal Éthier, Marc Bilodeau, Grace Chan, Xiaoyan Chu, Pierre–Michel Huet, Bernard Rocheleau, Raymond Evers, Iain P. Fraser, Scott Rasmussen and Luzelena Caro and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Hepatology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Robert Houle

25 papers receiving 572 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Houle Canada 14 235 146 136 123 121 26 577
Sujata Vaidyanathan United States 19 203 0.9× 95 0.7× 126 0.9× 137 1.1× 98 0.8× 36 1.4k
Agneta Norén Sweden 13 433 1.8× 220 1.5× 229 1.7× 127 1.0× 132 1.1× 20 832
Byung Min Ahn South Korea 11 191 0.8× 155 1.1× 124 0.9× 165 1.3× 49 0.4× 30 525
Brandon Swift United States 13 405 1.7× 181 1.2× 212 1.6× 137 1.1× 183 1.5× 23 861
Hiromi Okabe Japan 12 316 1.3× 50 0.3× 89 0.7× 112 0.9× 70 0.6× 16 640
P. Neuhaus Germany 8 202 0.9× 86 0.6× 288 2.1× 55 0.4× 85 0.7× 11 652
Eve‐Irene Lepist United States 16 278 1.2× 132 0.9× 99 0.7× 169 1.4× 199 1.6× 22 975
E. Musch Germany 14 152 0.6× 61 0.4× 84 0.6× 130 1.1× 38 0.3× 44 623
Anna Vildhede United States 13 583 2.5× 108 0.7× 349 2.6× 181 1.5× 251 2.1× 23 979

Countries citing papers authored by Robert Houle

Since Specialization
Citations

This map shows the geographic impact of Robert Houle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Houle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Houle more than expected).

Fields of papers citing papers by Robert Houle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Houle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Houle. The network helps show where Robert Houle may publish in the future.

Co-authorship network of co-authors of Robert Houle

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Houle. A scholar is included among the top collaborators of Robert Houle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Houle. Robert Houle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yabut, Jocelyn, et al.. (2022). Selection of an Optimal In Vitro Model to Assess P-gp Inhibition: Comparison of Vesicular and Bidirectional Transcellular Transport Inhibition Assays. Drug Metabolism and Disposition. 50(7). 909–922. 5 indexed citations
2.
3.
Bleasby, Kelly, Robert Houle, Michael J. Hafey, et al.. (2021). Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters. Viruses. 13(8). 1566–1566. 17 indexed citations
4.
Hafey, Michael J., Robert Houle, Keith Q. Tanis, et al.. (2020). A Two-Tiered In Vitro Approach to De-Risk Drug Candidates for Potential Bile Salt Export Pump Inhibition Liabilities in Drug Discovery. Drug Metabolism and Disposition. 48(11). 1147–1160. 14 indexed citations
5.
Houle, Robert, et al.. (2019). Effects of PEG200 and PEG400 on human renal uptake/efflux transporters. Drug Metabolism and Pharmacokinetics. 34(1). S72–S72. 1 indexed citations
6.
Chan, Grace, Robert Houle, Meihong Lin, et al.. (2019). Role of transporters in the disposition of a novel β-lactamase inhibitor: relebactam (MK-7655). Journal of Antimicrobial Chemotherapy. 74(7). 1894–1903. 13 indexed citations
7.
Prueksaritanont, Thomayant, Xiaoyan Chu, Raymond Evers, et al.. (2014). Pitavastatin is a more sensitive and selective organic anion‐transporting polypeptide1Bclinical probe than rosuvastatin. British Journal of Clinical Pharmacology. 78(3). 587–598. 144 indexed citations
8.
Rizk, Matthew L., et al.. (2013). Raltegravir Has a Low Propensity To Cause Clinical Drug Interactions through Inhibition of Major Drug Transporters: an In Vitro Evaluation. Antimicrobial Agents and Chemotherapy. 58(3). 1294–1301. 24 indexed citations
9.
Cauchon, Elizabeth, Austin Chen, Amandine Chefson, et al.. (2012). Design and synthesis of potent, isoxazole-containing renin inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(8). 2670–2674. 9 indexed citations
10.
McIntosh, David E., et al.. (2011). Robert Houle's Paris / Ojibwa.
11.
Aspiotis, Renée, Austin Chen, Elizabeth Cauchon, et al.. (2011). The discovery and synthesis of potent zwitterionic inhibitors of renin. Bioorganic & Medicinal Chemistry Letters. 21(8). 2430–2436. 7 indexed citations
12.
Boyd, Michael J., John Colucci, Carl Berthelette, et al.. (2011). New indole amide derivatives as potent CRTH2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(11). 3471–3474. 15 indexed citations
13.
Lévesque, Jean-François, Kelly Bleasby, Amandine Chefson, et al.. (2011). Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents. Bioorganic & Medicinal Chemistry Letters. 21(18). 5547–5551. 9 indexed citations
14.
Chen, Austin, Renée Aspiotis, Louis‐Charles Campeau, et al.. (2011). Renin inhibitors for the treatment of hypertension: Design and optimization of a novel series of spirocyclic piperidines. Bioorganic & Medicinal Chemistry Letters. 21(24). 7399–7404. 11 indexed citations
15.
Leblanc, Yves, Carl Berthelette, Carmela Molinaro, et al.. (2010). Azaindoles as potent CRTH2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(2). 841–845. 21 indexed citations
16.
Chen, Austin, Daniel Dubé, Sébastien Gagné, et al.. (2010). Addressing time-dependent CYP 3A4 inhibition observed in a novel series of substituted amino propanamide renin inhibitors, a case study. Bioorganic & Medicinal Chemistry Letters. 20(17). 5074–5079. 12 indexed citations
17.
Raymond, Valérie‐Ann, Chantal Éthier, Robert Houle, et al.. (2009). Primary cultures of human hepatocytes isolated from hepatitis C virus‐infected cirrhotic livers as a model to study hepatitis C infection. Liver International. 29(6). 942–949. 7 indexed citations
18.
Gauthier, Jacques Yves, W. Cameron Black, Wanda Cromlish, et al.. (2007). The identification of potent, selective, and bioavailable cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(17). 4929–4933. 51 indexed citations
19.
Houle, Robert, Jean‐Luc Raoul, Jean-François Lévesque, et al.. (2003). Retention of Transporter Activities in Cryopreserved, Isolated Rat Hepatocytes. Drug Metabolism and Disposition. 31(4). 447–451. 25 indexed citations
20.
Bilodeau, Marc, et al.. (1999). Evaluation of hepatocyte injury following partial ligation of the left portal vein. Journal of Hepatology. 30(1). 29–37. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sujata Vaidyanathan Breakdown of academic impact, for papers by Agneta Norén Breakdown of academic impact, for papers by Byung Min Ahn Breakdown of academic impact, for papers by Brandon Swift Breakdown of academic impact, for papers by Hiromi Okabe Breakdown of academic impact, for papers by P. Neuhaus Breakdown of academic impact, for papers by Eve‐Irene Lepist Breakdown of academic impact, for papers by E. Musch Breakdown of academic impact, for papers by Anna Vildhede
Rankless by CCL
2026